ArticleJournal of clinical medicine2021

Real-Life Analysis with Erenumab: First Target Therapy in the Episodic and Chronic Migraine's Prophylaxis.

Zaira Maraia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.